Open original FDA record ↗Recall record
- FDA identifier
- Z-0628-03
- Company in FDA record
- Biomerieux, Inc.
- FDA classification date
- Mar 6, 2003
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Vial to vial variability which can result in prolonged clot times.
Source facts
- Action
- Consignees were notified by letter via regular mail on December 23, 2002. They were advised to cease using the product, pull affected lot numbers, destroy the material and contact bioMerieux for replacement. Expanded recall 3/18/2003, consignees were notified by letter on March 19th , and March 31, 2003. Consignees were advised to stop using the affected lot numbers, destroy the remaining material in inventory and to contact their local bioMerieux Customer Service representative for replacement.
- Initiated
- 2002-12-23
- Root cause
- Other
- Terminated
- 2004-01-21
- Distribution
- CA, CO, FL, GA, IA, IN, MN, NC, NJ, TN, WI. Australia, Brazil, Buenos Aires, Canada, Colombia, Hong Kong, Japan, Korea, Mexico, Netherlands, Thailand and the United Kingdom. There were no government accounts involved.
- Recall number
- Z-0628-03
- Recall status
- Terminated
- CDRH record ID
- 25667
- FDA classified
- 2003-03-06
- Recall event number
- 25366